Stephen Gehlbach to Osteoporosis
This is a "connection" page, showing publications Stephen Gehlbach has written about Osteoporosis.
Connection Strength
1.743
-
Gehlbach S, Hooven FH, Wyman A, Diez-Perez A, Adachi JD, Luo X, Bushmakin AG, Anderson FA. Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). PLoS One. 2013; 8(12):e82840.
Score: 0.410
-
Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S, Chapurlat RD, Compston JE, Cooper C, D?ez-Perez A, Greenspan SL, LaCroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Sambrook PN, Silverman S, Siris ES, Watts NB, Lindsay R. Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res. 2012 Mar; 27(3):645-53.
Score: 0.362
-
D?ez-P?rez A, Hooven FH, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Delmas P, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris ES, Watts NB, Nika G, Gehlbach SH. Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 2011 Sep; 49(3):493-8.
Score: 0.343
-
Gehlbach SH, Avrunin JS, Puleo E. Trends in hospital care for hip fractures. Osteoporos Int. 2007 May; 18(5):585-91.
Score: 0.252
-
Guggina P, Flahive J, Hooven FH, Watts NB, Siris ES, Silverman S, Roux C, Pfeilschifter J, Greenspan SL, D?ez-P?rez A, Cooper C, Compston JE, Chapurlat R, Boonen S, Adachi JD, Anderson FA, Gehlbach S. Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone. 2012 Dec; 51(6):975-80.
Score: 0.094
-
FitzGerald G, Boonen S, Compston JE, Pfeilschifter J, LaCroix AZ, Hosmer DW, Hooven FH, Gehlbach SH. Differing risk profiles for individual fracture sites: evidence from the Global Longitudinal Study of Osteoporosis in Women (GLOW). J Bone Miner Res. 2012 Sep; 27(9):1907-15.
Score: 0.094
-
Adachi JD, Adami S, Gehlbach S, Anderson FA, Boonen S, Chapurlat RD, Compston JE, Cooper C, Delmas P, D?ez-P?rez A, Greenspan SL, Hooven FH, LaCroix AZ, Lindsay R, Netelenbos JC, Wu O, Pfeilschifter J, Roux C, Saag KG, Sambrook PN, Silverman S, Siris ES, Nika G, Watts NB. Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc. 2010 Sep; 85(9):806-13.
Score: 0.081
-
Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL. Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol. 2006 Aug; 33(8):1651-7.
Score: 0.061
-
Burge R, Puleo E, Gehlbach S, Worley D, Klar J. Inpatient hospital and post-acute care for vertebral fractures in women. Value Health. 2002 Jul-Aug; 5(4):301-11.
Score: 0.046